We studied 476 patients affected by diabetes: 166 male (mean age 61.6 ± 10 years, range 27–91) and 310 female (mean age 61.5 ± 8.4 years, range 25–82). Mean disease duration was 11.3 ± 7.6 years, range 0.3–37).All patients underwent surface motor and sensory nerve conduction along median, popliteal, and sural nerve.Results. Median nerve: in 3.1% of subjects sensory action potentials (SAP) was absent; sensory nerve conduction velocity (SNCV) was reduced in 41.8% in distal segment and in 27.5% in the proximal segment. Motor nerve conduction (MNCV) was reduced in 29.9% of the subjects.Sural nerve: SAP was absent in 24.4% and SNCV was reduced in 32.7%.Popliteal nerve: MNCV was abnormal in 30.4% of the subjects. Combining electrophysiological data we observed that:1. 28.6% of the subjects resulted normal2. 12.8% were affected by a lower limbs sensory neuropathy3. 0.2% had a lower limbs motor neuropathy4. 5.9% had a lower limbs sensory‐motor neuropathy5. 6.1% had a diffused sensory neuropathy6. 30.2% had a diffused sensory‐motor neuropathy7. 16.2% had a carpal tunnel syndrome.Patients were divided in 2 groups: patients with and patients without neuropahy: the latter showed a significantly shorter disease duration (12.7 ± 8.1 vs 9.0 ± 6.3; p < 0.0001).In addition, we observed a significant correlation between disease duration and distal latency, median and popliteal MNCV, and SNCV in median and sural nerve (Regression test; p < 0.0001).Patients on insulin showed a longer disease duration and more severe electrophysiological abnormalities.
Read full abstract